We are live on ! Find out more
OIMU

Orbis Investment Management (US) Portfolio holdings

AUM $99.7M
1-Year Est. Return 17.51%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
-17.51%
3 Year Est. Return
+48.85%
5 Year Est. Return
+64.6%
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$3.15M
Cap. Flow
+$4.14M
Cap. Flow %
3.48%
Top 10 Hldgs %
63.41%
Holding
26
New
4
Increased
3
Reduced
8
Closed
3

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$5.56M
2
ELV icon
Elevance Health
ELV
+$3.45M
3
HUM icon
Humana
HUM
+$3.33M
4
AGN
Allergan plc
AGN
+$2.73M
5
BHI
Baker Hughes
BHI
+$2.51M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.46M
2
AAPL icon
Apple
AAPL
+$3.11M
3
MSFT icon
Microsoft
MSFT
+$2.22M
4
AMGN icon
Amgen
AMGN
+$2.08M
5
CLH icon
Clean Harbors
CLH
+$886K

Sector Composition

Rank Sector Weight
1 Healthcare 23.62%
2 Financials 18.56%
3 Technology 17.79%
4 Industrials 16.35%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XPO icon
1
XPO
XPO
$23.4B
$12.8M 10.75%
1,408,866
+219,187
+18% +$2.18M
QCOM icon
2
Qualcomm
QCOM
$160B
$12.5M 10.47%
232,703
– –
MSI icon
3
Motorola Solutions
MSI
$71.5B
$8.7M 7.31%
131,941
-5,921
-4% -$421K
LBRDK icon
4
Liberty Broadband Class C
LBRDK
$4.79B
$7.22M 6.07%
120,367
– –
CLH icon
5
Clean Harbors
CLH
$16.8B
$6.66M 5.6%
127,823
-17,712
-12% -$886K
APA icon
6
APA Corp
APA
$12.8B
$6.18M 5.2%
111,104
-10,291
-8% -$560K
ABBV icon
7
AbbVie
ABBV
$455B
$5.9M 4.96%
95,367
-10,408
-10% -$634K
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.63M 4.73%
+38,911
New +$5.56M
CELG
9
DELISTED
Celgene Corp
CELG
$5.13M 4.31%
52,007
– –
C icon
10
Citigroup
C
$222B
$4.76M 4%
112,397
– –
PYPL icon
11
PayPal
PYPL
$49.3B
$4.6M 3.86%
125,976
– –
CHTR icon
12
Charter Communications
CHTR
$16.9B
$4.37M 3.67%
19,114
-2,026
-10% -$435K
MCK icon
13
McKesson
MCK
$101B
$3.77M 3.17%
20,193
– –
MRK icon
14
Merck
MRK
$321B
$3.75M 3.15%
68,273
-102,598
-60% -$5.46M
AIG icon
15
American International
AIG
$41.8B
$3.6M 3.02%
68,066
-3,224
-5% -$178K
CCL icon
16
Carnival Corporation Ltd
CCL
$38B
$3.56M 3%
80,651
+12,908
+19% +$633K
AET
17
DELISTED
Aetna Inc
AET
$3.5M 2.94%
28,628
– –
ELV icon
18
Elevance Health
ELV
$81.6B
$3.45M 2.9%
26,274
+25,189
+2,322% +$3.45M
HUM icon
19
Humana
HUM
$44B
$3.37M 2.83%
+18,736
New +$3.33M
AGN
20
DELISTED
Allergan plc
AGN
$2.73M 2.3%
+11,827
New +$2.73M
BHI
21
DELISTED
Baker Hughes
BHI
$2.5M 2.1%
+55,495
New +$2.51M
PRKS icon
22
United Parks & Resorts
PRKS
$2.15B
$2.25M 1.89%
157,368
– –
AA icon
23
Alcoa
AA
$11.9B
$2.09M 1.75%
93,638
-11,297
-11% -$264K
AAPL icon
24
Apple
AAPL
$4.9T
– –
-114,056
Closed -$3.11M
AMGN icon
25
Amgen
AMGN
$209B
– –
-13,897
Closed -$2.08M
1
2

Similar funds

BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
DCM
Diag Capital Management New York $87.4M AUM
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
CFA
Clarfeld Financial Advisors Tarrytown, New York $120M AUM
BPV
Battery Partners VIII Boston, Massachusetts $121M AUM 101.35% 1-Year Est. Return

Orbis Investment Management (US)'s Q2 2016 Portfolio in Review

As of Q2 2016, Orbis Investment Management (US) held 26 positions worth $119M, up 2.7% from $116M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Orbis Investment Management (US) deployed $4.14M of net new capital in Q2 2016, opening 4 new positions and adding to 3 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 38,911 shares worth $5.63M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Merck, an estimated $5.46M trimmed.

  • Orbis Investment Management (US)'s largest Q2 2016 buy was Berkshire Hathaway Class B: 38,911 shares worth $5.63M.
  • Orbis Investment Management (US) added most to Elevance Health in Q2 2016, an estimated $3.45M increase.
  • Orbis Investment Management (US)'s biggest Q2 2016 reduction was Merck, cutting an estimated $5.46M.
  • Orbis Investment Management (US) fully exited Apple in Q2 2016, selling an estimated $3.11M.
  • Orbis Investment Management (US)'s ten largest holdings make up 63% of its $119M portfolio in Q2 2016.
  • Orbis Investment Management (US) opened 4 new positions and closed 3 in Q2 2016.
  • Orbis Investment Management (US)'s portfolio value rose 2.7% quarter-over-quarter to $119M.

Based on Orbis Investment Management (US)'s 13F filing for Q2 2016, filed 15 Aug 2016.